Two Firms Steer Korean Consortium's $1.5 Billion Bioscience Deal – Bloomberg Law
Paul Hastings is advising a Korean private equity-backed consortium on its take-private deal for Meridian Bioscience, Inc., a provider of
See Original Article
Leave a Reply